Article
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells
17 Nov 2017
Abstract excerpt
Precise rare-cell technologies require the blood to be processed immediately or be stabilized with fixatives. Such restrictions limit the translation of circulating tumor cell (CTC)-based liquid biopsy assays that provide accurate molecular data in guiding clinical decisions. Here we describe a method to preserve whole blood in its minimally altered state by combining hypothermic preservation with targeted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
